Tag Archives: Dr Lucinda bateman

Inclusion of family members without ME/CFS in research studies promotes discovery of biomarkers specific for ME/CFS

Posted on 08/04/2020 by wames

Inclusion of family members without ME/CFS in research studies promotes discovery of biomarkers specific for ME/CFS, by  in Work 2020 [DOI: 10.3233/WOR-203177]   Research abstract: BACKGROUND: The search for a biomarker specific for ME/CFS (myalgic encephalomyelitis/chronic fatigue syndrome) has been long, … Continue reading →

Posted in News | Tagged , , , , , , , , , , | Comments Off on Inclusion of family members without ME/CFS in research studies promotes discovery of biomarkers specific for ME/CFS

Plasma proteomic profiling suggests an association between antigen driven clonal B cell expansion & ME/CFS

Posted on 07/24/2020 by wames

Plasma proteomic profiling suggests an association between antigen driven clonal B cell expansion and ME/CFS, by Milica Milivojevic, Xiaoyu Che, Lucinda Bateman, Aaron Cheng, Benjamin A Garcia, Mady Hornig, Manuel Huber, Nancy G Klimas,Bohyun Lee, Hyoungjoo Lee, Susan Levine, Jose G … Continue reading →

Posted in News | Tagged , , , , , , , , , , , , , , , , , , | Comments Off on Plasma proteomic profiling suggests an association between antigen driven clonal B cell expansion & ME/CFS

ME/CFS & Covid-19: information for you & your doctor

Posted on 03/30/2020 by wames

COVID-19 Information and Resources – Bateman Horne Center, March 2020   The Bateman Horne Center works for the medical advancement and treatment of  Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome (ME/CFS)and Fibromyalgia in Salt Lake City, Utah, USA. In addition to the … Continue reading →

Posted in News | Tagged , , , , , , , , | Comments Off on ME/CFS & Covid-19: information for you & your doctor

Perturbation of effector & regulatory T cell subsets in ME/CFS

Posted on 01/09/2020 by wames

Perturbation of effector and regulatory T cell subsets in Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome (ME/CFS), by Ece Karhan, Courtney Gunter, Vida Ravanmehr, Meghan Horne, Lina Kozhaya, Stephanie Renzullo, Lindsey Placek, Joshy George, Peter N Robinson, Suzannne D Vernon, Lucinda Bateman, … Continue reading →

Posted in News | Tagged , , , , , , , , , , , , , , , , | Comments Off on Perturbation of effector & regulatory T cell subsets in ME/CFS

Video lecture by Dr Lucinda Bateman: Upright activity & exercise intolerance: critical concepts in the evaluation of chronic fatigue

Posted on 11/12/2019 by wames

Upright activity and exercise intolerance: critical concepts in the evaluation of chronic fatigue, by Dr Lucinda Bateman   Dr Bateman talks to doctors.  Duration 56 minutes. Topics covered: how she assesses and diagnoses patients with ME/CFS the questionnaires she gets … Continue reading →

Posted in News | Tagged , , , , | Comments Off on Video lecture by Dr Lucinda Bateman: Upright activity & exercise intolerance: critical concepts in the evaluation of chronic fatigue

Estimating prevalence, demographics & costs of ME/CFS using large scale medical claims data & Machine Learning (US)

Posted on 01/29/2019 by wames

Estimating prevalence, demographics and costs of ME/CFS using large scale medical claims data and machine learning, by Ashley Valdez, Elizabeth E. Hancock, Seyi Adebayo, David Kiernicki, Daniel Proskauer, John R. Attewell, Lucinda Bateman, Alfred DeMaria, Jr, Charles W. Lapp, Peter … Continue reading →

Posted in News | Tagged , , , , , , , , , , , , , , , | Comments Off on Estimating prevalence, demographics & costs of ME/CFS using large scale medical claims data & Machine Learning (US)

Insights into ME/CFS phenotypes through comprehensive metabolomics

Posted on 07/13/2018 by wames

Research abstract: Insights into myalgic encephalomyelitis/chronic fatigue syndrome phenotypes through comprehensive metabolomics, by Dorottya Nagy-Szakal, Dinesh K. Barupal, Bohyun Lee, Xiaoyu Che, Brent L. Williams, Ellie J. R. Kahn, Joy E. Ukaigwe, Lucinda Bateman, Nancy G. Klimas, Anthony L. Komaroff, … Continue reading →

Posted in News | Tagged , , , , , , , , , , , , , , , , , , | Comments Off on Insights into ME/CFS phenotypes through comprehensive metabolomics

KPAX002 as a treatment for ME/CFS – disappointing trial results

Posted on 04/17/2018 by wames

  Research abstract: KPAX002 as a treatment for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): a prospective, randomized trial, by Jose G Montoya, Jill N Anderson, Danya L Adolphs, Lucinda Bateman, Nancy Klimas, Susan M Levine, Donn W Garvert, Jon D Kaiser … Continue reading →

Posted in News | Tagged , , , , , , , , , , , , | Comments Off on KPAX002 as a treatment for ME/CFS – disappointing trial results

Much can be done to ease ‘CFS’ symptoms – US 2018 Clinician Summit reports

Posted on 04/11/2018 by wames

Reports from the 2 day ME/CFS Clinician Summit 2018 held in Salt Lake City Utah. 1. Bateman Horne Center blog post, by Stephanie Griffin, 12 March 2018: A consensus-driven ME/CFS clinician coalition takes shape The primary outcomes are two-fold. First, an evidence-based … Continue reading →

Posted in News | Tagged , , , | Comments Off on Much can be done to ease ‘CFS’ symptoms – US 2018 Clinician Summit reports

Cortene – a new drug trial & disease hypothesis for ME/CFS

Posted on 03/26/2018 by wames

Cortene In his blog, Health Rising, Cort Johnson introduces a new drug trial and hypothesis for ME/CFS. With the help of Dr Lucinda Bateman and Dr Suzanne Vernon a small drug company, Cortene, will be conducting a small proof-of-concept trial of a new … Continue reading →

Posted in News | Tagged , , , , , | Comments Off on Cortene – a new drug trial & disease hypothesis for ME/CFS